Tetrahydrofolic acid
Based on 6 publication(s) in Google Scholar
Tetrahydrofolic acid (L-5,6,7,8-Tetrahydrofolic acid) is the biologically active vitamin B9 folate derivative. Tetrahydrofolic acid is a donor of one-carbon groups for amino acids, nucleic acids, and lipids. Tetrahydrofolic acid serves as an acceptor of free formaldehyde, producing 5,10-methylenetetrahydrofolate-Tetrahydrofolic acid.
For research use only. We do not sell to patients.
- Purity : 96.77%
- CAS No.: 135-16-0
- Formula: C19H23N7O6
- Molecular Weight:445.43
-
Storage:
-80°C, protect from light, stored under nitrogen
* The compound is unstable in solutions, freshly prepared is recommended.
Publications Citing Use of MedChemExpress (MCE) Tetrahydrofolic acid
More- Nat Commun. 2025 Jan 31;16(1):1233. [Abstract]
- J Adv Res. 2026 Mar 5:S2090-1232(26)00188-8. [Abstract]
- Mol Cell. 2025 Jul 17;85(14):2759-2775.e12. [Abstract]
- Int J Biol Macromol. 2025 Feb:290:139041. [Abstract]
- J Biol Chem. 2022 Nov;298(11):102548. [Abstract]
- J Pharm Biomed Anal. 2026 Jan 15:268:117178. [Abstract]
-
2D/3D Cell Culture and Differentiation
-
Bio/Physico-chemical Assay
-
Bio/Physico-chemical Assay
-
Cell Proliferation/Viability Assay
-
Cell Imaging/Staining
All Endogenous Metabolite Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Human Endogenous Metabolite |
In Vitro
Tetrahydrofolic acid (0-200 μM; 3 days; Adh5-/- DT40 cells) exposure is cytotoxic to Adh5- and Fanconi anemia (FA)-deficient cells due to the accumulation of extensive DNA damage and chromosome breaks[1].
Tetrahydrofolic acid (0-100 μM; 16 hours; Adh5-/- DT40 cells) treatment strongly promots FANCD2 and ser139-H2AX focus formation in Adh5-/- cells in a dose-dependent manner[1].
Tetrahydrofolic acid exposure activates the DNA damage response (DDR) due to uncontrolled activity of the thymidylate synthase enzyme, which causes a depletion of essential nucleotides, and promotes repair by a homologous recombination mechanism[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Adh5-/- DT40 cells
-
Concentration:0-200 µM
-
Incubation Time:3 days
-
Result:Viability of Adh5-/- DT40 cells rapidly dropped.
-
Cell Line:Adh5-/- DT40 cells
-
Concentration:0-200 µM
-
Incubation Time:16 hours
-
Result:Strongly promoted FANCD2 and ser139-H2AX focus formation in Adh5-/- cells in a dose-dependent manner.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Adh5-/- mice[1]
-
Dosage:62.5 mg/kg
-
Administration:Intraperitoneal injection; daily
-
Result:Perturbed hematopoiesis, increased ser139-H2AX phosphorylation, and decreased the survival of progenitor cells (HSPCs).
Chemical Information
-
CAS No. 135-16-0
-
Appearance Solid
-
Molecular Weight 445.43
-
Formula C19H23N7O6
-
Color Light brown to brown
-
SMILES
NC(NC1=C2NC(CNC3=CC=C(C(N[C@@H](CCC(O)=O)C(O)=O)=O)C=C3)CN1)=NC2=O
-
Synonyms
L-5,6,7,8-Tetrahydrofolic acid; L-Tetrahydrofolic acid
-
Structure Classification
-
Initial Source
-
Shipping
Shipping with dry ice.
-
Storage
-80°C, protect from light, stored under nitrogen
* The compound is unstable in solutions, freshly prepared is recommended.
Publications (6)
-
Journal Impact Factor
-
Most Recent
-
Nat Commun
2025 Jan 31;16(1):1233. PMID: 39890804
Tetrahydrofolic acid purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 Jan 31;16(1):1233. [Abstract]
Micehepatocytes were pretreated with indicated concentrations of L-methionine (L-Met) or tetrahydrofolic acid (THF) for 2 h before adding 200 μM DCA for 4 h.
-
J Adv Res
A novel zebrafish model unveils folate deficiency disrupts embryonic development via p53-driven cell cycle arrest. [Abstract]2026 Mar 5:S2090-1232(26)00188-8. PMID: 41794221 -
Mol Cell
Microprotein SMIM26 drives oxidative metabolism via serine-responsive mitochondrial translation. [Abstract]2025 Jul 17;85(14):2759-2775.e12. PMID: 40578345 -
Int J Biol Macromol
Tetrahydrofolic acid accelerates amyloid fibrillization, decreases cytotoxic oligomers and suppresses their toxicity. [Abstract]2025 Feb:290:139041. PMID: 39708879
Tetrahydrofolic acid purchased from MedChemExpress. Usage Cited in: Int J Biol Macromol. 2025 Feb:290:139041. [Abstract]
The effect of Tetrahydrofolic acid (25-75 μM) on the aggregation of αS and Aβ was monitored by ThT fluorescence.
Tetrahydrofolic acid purchased from MedChemExpress. Usage Cited in: Int J Biol Macromol. 2025 Feb:290:139041. [Abstract]
αS, Aβ40, and Aβ42 were incubated for 340 h, 110 h, and 20 h, respectively, in the absence or presence of a specified proportion of Tetrahydrofolic acid for AFM analysis. Scale bars = 1 μm.
Tetrahydrofolic acid purchased from MedChemExpress. Usage Cited in: Int J Biol Macromol. 2025 Feb:290:139041. [Abstract]
The effect of 50 μM αS, 25 μM Aβ40 and 25 μM Aβ42 aggregates on cell viability without or with different concentrations of Tetrahydrofolic acid (25-100 μM; 48 h) was determined by MTT assay.
Tetrahydrofolic acid purchased from MedChemExpress. Usage Cited in: Int J Biol Macromol. 2025 Feb:290:139041. [Abstract]
Tetrahydrofolic acid (75-100 μM; 72 h) accelerates amyloid aggregation in C. elegans.
-
J Biol Chem
Elucidation of the substrate of tRNA-modifying enzymes MnmEG leads to in vitro reconstitution of an evolutionarily conserved uridine hypermodification. [Abstract]2022 Nov;298(11):102548. PMID: 36181794 -
J Pharm Biomed Anal
A rapid LC-MS/MS method for the simultaneous quantification of 10 key folate cycle intermediates in human plasma. [Abstract]2026 Jan 15:268:117178. PMID: 41061512
Solvent & Solubility
In Vitro:
DMSO : 116.67 mg/mL (261.93 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (276 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.2450 mL | 11.2251 mL | 22.4502 mL | 56.1255 mL |
| 5 mM | 0.4490 mL | 2.2450 mL | 4.4900 mL | 11.2251 mL | |
| 10 mM | 0.2245 mL | 1.1225 mL | 2.2450 mL | 5.6126 mL | |
| 15 mM | 0.1497 mL | 0.7483 mL | 1.4967 mL | 3.7417 mL | |
| 20 mM | 0.1123 mL | 0.5613 mL | 1.1225 mL | 2.8063 mL | |
| 25 mM | 0.0898 mL | 0.4490 mL | 0.8980 mL | 2.2450 mL | |
| 30 mM | 0.0748 mL | 0.3742 mL | 0.7483 mL | 1.8709 mL | |
| 40 mM | 0.0561 mL | 0.2806 mL | 0.5613 mL | 1.4031 mL | |
| 50 mM | 0.0449 mL | 0.2245 mL | 0.4490 mL | 1.1225 mL | |
| 60 mM | 0.0374 mL | 0.1871 mL | 0.3742 mL | 0.9354 mL | |
| 80 mM | 0.0281 mL | 0.1403 mL | 0.2806 mL | 0.7016 mL | |
| 100 mM | 0.0225 mL | 0.1123 mL | 0.2245 mL | 0.5613 mL |